Results

Total Results: 3,789 records

Showing results for "choice".

  1. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - treatment and comparator groups were imbalanced in terms of factors that were common causes of both the choice
  2. integrationacademy.ahrq.gov/sites/default/files/2025-06/Innovations%20in%20Behavioral%20Health%20Integration_Transcript.docx
    January 01, 2025 - Stephens: equivalent or appropriate on that level, and then someone of their choice that they thought
  3. hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2019.pdf
    September 01, 2021 - The choice of an appropriate method for calculating variances for nationwide estimates depends on the
  4. www.ahrq.gov/sites/default/files/publications2/files/MeasureDx-guide.pdf
    July 01, 2022 - The choice of measurement strategy depends on your diagnostic safety team’s goals, expertise, technical
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_executive.pdf
    March 01, 2013 - 1 Comparative Effectiveness Review Number 94 Interventions for Feeding and Nutrition in Cerebral Palsy Executive Summary Background Cerebral palsy (CP) is a “group of disorders of the development of movement and posture, causing activity limitation, that is attributed to non-progressive disturbances that…
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
    April 01, 2012 - 1 Comparative Effectiveness Review Number 60 Treatment for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment and blindness both in the United States and worldwide. It is estimated to affect 60.5 million people worldwide.1 Glaucoma is defined as…
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - 1 Comparative Effectiveness Review Number 86 Treatment for Restless Legs Syndrome Executive Summary Introduction Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and a distressing, irresistible urge to move them. RLS can result in reduced quality o…
  8. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
    September 01, 2011 - Layout 1 Background Antipsychotics medications are approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These medications are commonly divided into two classes, reflecting two waves of historical development: the conventional antipsychotics and the atypical. T…
  9. digital.ahrq.gov/sites/default/files/docs/page/D_ITPrivacyandSecurityPrimer_1.pdf
    March 20, 1997 - D_ITPrivacyandSecurityPrimer Appendix D: IT Privacy and Security Primer PART 1: GENERAL PRIVACY CONSIDERATIONS1 Introduction The purpose of this IT Privacy and Security Primer is to provide a broad overview of what privacy in health care represents. This section is not intended to address the state a…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
    January 01, 2014 - 1 Comparative Effectiveness Review Number 127 Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities Executive Summary Background Venous leg ulcers are extremely common in the United States. They affect between 500,000 and 2 million people annually, and are responsible for over 50 pe…
  11. www.ahrq.gov/sites/default/files/publications/files/clabsicompanion.pdf
    October 18, 2012 - Eliminating CLABSI, A National Patient Safety Imperative: Final Report Companion Guide Eliminating CLABSI, A National Patient Safety Imperative A Companion Guide to the National On the CUSP: Stop BSI Project Final Report A Project of: Health Research & Educational Trust Johns Hopkins Medicine A…
  12. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
    November 01, 2019 - High-Risk Deliveries at Facilities with Level 3 or Higher NICU Services on Campus 1 High-Risk Deliveries at Facilities with Level 3 or Higher NICU Services on Campus Section 1. Basic Measure Information 1.A. Measure Name High-Risk Deliveries at Facilities with Level 3 or Higher NICU Services on Campus 1.B. Me…
  13. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-fullreport.pdf
    September 01, 2019 - High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services - Report High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services Available Section 1. Basic Measure Information 1.A. Measure Name High-Risk Deliveries at Facilities with 24/7 In-House Blood B…
  14. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpForm.pdf
    August 01, 2012 - NCINQ Measure Submission: Tobacco Use and Help with Quitting Among Adolescents Attachment A: CHIPRA Pediatric Quality Measures Program (PQMP) Candidate Measure Submission Form (CPCF) Italics indicate instructions for how to complete a specific field. << >> indicates the name of a text field in the online version o…
  15. digital.ahrq.gov/sites/default/files/docs/page/D_ITPrivacyandSecurityPrimer_0.pdf
    March 20, 1997 - D_ITPrivacyandSecurityPrimer Appendix D: IT Privacy and Security Primer Privacy and Security Assessment of Variation Toolkit D-1 PART 1: GENERAL PRIVACY CONSIDERATIONS1 Introduction The purpose of this IT Privacy and Security Primer is to provide a broad overview of what privacy in health …
  16. meps.ahrq.gov/data_files/publications/mr12/mr12.pdf
    June 01, 2001 - Methodology Report #12: Outpatient Prescription Drugs: Data Collection and Editing in the 1996 Medical Expenditure Survey (HC-010A) ����� ����� yyyyy yyyyyReport 12 Outpatient Prescription Drugs: Data Collection and Editing in the 1996 Medical Expenditure Panel Survey (HC-010A) Methodology Methodology U.S. De…
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_executive.pdf
    December 01, 2014 - 1 Radiotherapy Treatments for Head and Neck Cancer Update Executive Summary Introduction Objectives In May 2010, the Agency for Healthcare Research and Quality (AHRQ) published the results of Comparative Effectiveness Review (CER) No. 20, “Comparative Effectiveness and Safety of Radiotherapy Treatments for H…
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/hDZUZdx4qLNc2PjbkfWQuw
    April 01, 2016 - Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies Jeanne S. Mandelblatt, MD, MPH; Natasha K. Stout, PhD; Clyde B. Schechter, MA, MD; Jeroen J. van den Broek, MS; Diana L. Miglioretti, PhD; Martin Krapcho, BS; Amy Trentham-Dietz, PhD, MS; Diego Munoz, PhD,…
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_executive.pdf
    May 01, 2013 - 1 Comparative Effectiveness Review Number 95 Interventions To Modify Health Care Provider Adherence to Asthma Guidelines Executive Summary Background Asthma is a respiratory disease characterized by variable and recurring symptoms, airflow obstruction, bronchial hyper-responsiveness, and inflammation of the…
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_disposition-comments.pdf
    January 01, 2010 - While the Cochrane Risk of Bias tool is certainly a reasonable choice, the issue of blinding in behavioral